From Past Challenges to Current Innovations in Treatment of NMIBC

home / peer-exchange / from-past-challenges-to-current-innovations-in-treatment-of-nmibc

Experts discuss challenges with the current standard of care in non–-muscle-invasive bladder cancer (NMIBC); review data and emerging treatment options for high-risk, non–-bacille Calmette-Guérin responsive NMIBC, including drug delivery systems;, and share practical considerations for the adoption of new and emerging treatment options in NMIBC.

Standard of Care and Intravesical Chemotherapy in NMIBC

EP. 1: Standard of Care and Intravesical Chemotherapy in NMIBC

Chad A. Reichard, MD ;Karim Chamie, MD, MSHS ;R. Jonathan Henderson, MD;Joseph Jacob, MD, MCR
February 27th 2025

Experts discuss the standard of care and the use of intravesical chemotherapy in the treatment of non–muscle-invasive bladder cancer (NMIBC).

© 2025 MJH Life Sciences

All rights reserved.